New vaccine study targets sneaky pneumonia bacteria
NCT ID NCT07135453
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study tests whether two different pneumococcal vaccines can create antibodies that kill newly discovered types of pneumonia bacteria. Researchers will give healthy adults one of the vaccines and measure how well their immune system fights these bacteria. The goal is to see if current vaccines can protect against these new bacterial threats.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Freeze-Dried rabies vaccine aims to save lives in High-Risk regions
- New vaccine aims to shield kids from pneumonia and meningitis
- Mixing COVID-19 vaccines: could two different shots be better?
- New vaccine aims to shield babies from pneumonia and meningitis
- Which pneumonia vaccine works best for lymphoma patients? new study aims to find out
- New infant vaccine trial aims to shield against pneumonia and meningitis